<a href="https://www.fiercebiotech.com/medtech/herantis-taps-indivi-digital-biomarker-tech-parkinsons-disease-trial" hreflang="en">Herantis taps Indivi for digital biomarker tech in Parkinson’s disease trial</a>
fiercebiotech.com·May 19, 2026
Herantis Pharma is collaborating with Indivi to conduct a proof-of-concept clinical trial aimed at the early detection of Parkinson's disease.
The collaboration between Herantis Pharma and Indivi highlights a strategic push towards leveraging medtech for early detection in neurodegenerative diseases. This suggests an opportunity for investment in technologies that integrate biotech and medtech solutions for early diagnostic capabilities, particularly in conditions like Parkinson’s disease, which could lead to breakthroughs in precision medicine and digital health.